Expanding Access to Dental Care for Patients on Suboxone by White, Nathan E
University of Vermont
ScholarWorks @ UVM
Family Medicine Clerkship Student Projects Larner College of Medicine
2017
Expanding Access to Dental Care for Patients on
Suboxone
Nathan E. White
Larner College of Medicine at The University of Vermont
Follow this and additional works at: https://scholarworks.uvm.edu/fmclerk
Part of the Medical Education Commons, and the Primary Care Commons
This Book is brought to you for free and open access by the Larner College of Medicine at ScholarWorks @ UVM. It has been accepted for inclusion in
Family Medicine Clerkship Student Projects by an authorized administrator of ScholarWorks @ UVM. For more information, please contact
donna.omalley@uvm.edu.
Recommended Citation
White, Nathan E., "Expanding Access to Dental Care for Patients on Suboxone" (2017). Family Medicine Clerkship Student Projects.
251.
https://scholarworks.uvm.edu/fmclerk/251
Expanding access to 
Dental Care for Patients 
on Suboxone®
NATHAN WHITE, MSIII
LARNER COLLEGE OF MEDICINE AT THE UNIVERSITY OF VERMONT
FAMILY MEDICINE, APRIL 2017
COLCHESTER FAMILY PRACTICE
MENTOR: ALICIA JACOBS, MD
Problem Identification and Need
 Those using Suboxone® for medication assisted treatment for opioid 
dependence are at increased risk for poor oral health and medication 
assisted addiction treatment programs do not regularly address these 
concerns.
 Lifestyle  Self rated poor oral health is prevalent among current and former 
opioid users likely due to a variety of factors including poor nutrition, dental 
hygiene, and high rates of alcohol and tobacco use2.
 Direct effects of opioids  Suboxone® is made of up buprenorphine, a μ-
opioid receptor partial agonist and naloxone, a μ-opioid receptor 
antagonist in a 4:1 ratio. Opioids are known to cause xerostomia which is 
associated with periodontal disease3,9.
 Unique risks of Suboxone®  Suboxone® is administered as a sublingual film 
or tab which has a pH of 4.1, an acidic oral environment is associated with 
increased dental erosion3,8. 
Local Problem Identification
 Vermont leads the nation with the highest rate of prescriptions for 
buprenorphine being paid for my Medicaid11.
 Even though Medicaid provides some coverage of dental costs, 
lower income individuals are more likely to suffer from poor oral 
health1.
 Many dental offices are reluctant to accept Medicaid patients due 
to low reimbursement rates.
 In Vermont, Medicaid reimburses for dental care at 54.1% of 
commercial dental insurance charges7.
 Anecdotal evidence from local dentists and Suboxone® prescribers 
demonstrates increased rates of dental caries and periodontal 
disease among Suboxone® users.
Public Health Cost
 Although currently controversial, some studies have linked poor 
periodontal health to increased rates of systemic diseases such as 
respiratory diseases, chronic kidney disease, rheumatoid arthritis, 
cognitive impairment, obesity, metabolic syndrome and cancer4. 
 Poor self-perceived oral health has a significant impact on 
psychological well being, quality of life and life satisfaction. This has 
been demonstrated among the general population and 
intravenous drug users5,10.
 Investing in preventative dental care may prove to be cost 
effective by reducing the need for expensive non-preventative 
dental visits6.
Community Perspective
 Katera Hopkins, DMD; Program Director, Dental Residency Program, Larner College of Medicine at the 
University of Vermont. 
 Anecdotally, Suboxone® users tend to have poorer oral health than their age matched peers. Socioeconomic and 
lifestyle factors play a large role in this finding, however, Suboxone® also may also play a direct role by impacting the 
local oral environment. 
 Medicine and Dentistry have long been viewed as separate entities but they are intimately connected, a patient’s 
medical home and primary care provider can be a great place to start bridging this gap by educating about the 
importance of oral health and providing a direct connections to the dental community. 
 Medicaid provides great dental coverage for children and pregnant women, however, those outside of these groups 
receive very limited benefits.
 While local dentists in private practice may not accept Medicaid patients or accept limited numbers, dental practices 
such as the UVM Dental Residency Clinic, the Community Health Centers of Burlington and Vermont Dental Care 
accept all Medicaid patients. 
 John Chisholm, MD; Assistant Professor, Family Medicine, Larner College of Medicine at the University of 
Vermont.
 Dr. Chisholm manages many patients on Suboxone® for medication assisted treatment.
 Anecdotally, Suboxone® users tend to have accelerated deterioration of their oral health. These patients tend to have 
poorer oral health than would be expected for their age. Many factors likely play a role including lifestyle and access 
to dental care. 
 Many Suboxone® providers are not primary care physicians and may never think about referral for oral health. As a 
Suboxone® provider who is also a primary care physician it would be great to be able to provide these patients with 
education and options for their dental needs as part of their routine health maintenance. 
Intervention and Methodology
 Patients receiving Suboxone® treatment for opioid dependence 
see their prescribing provider on a regular basis. This provides a 
unique opportunity for education about the importance of oral 
health and intervention. My intervention will implement an 
educational pamphlet beginning in UVM Family Medicine practices 
that aims to:
 Remind and educate providers about the importance of screening this 
population for oral health concerns and promotion of preventative 
dental care 
 Educate patients about the importance of dental care and provide 
strategies for developing good oral health habits along with connecting 
them to local dental practices. 
 Promote oral health as an important aspect of overall well being 
especially in vulnerable populations. 
Results/Response
 Medical Providers – Providers at Colchester Family Practice that see 
patients on medication assisted treatment for opioid dependence 
responded positively. Many of these providers admit that managing 
patients on medication assisted treatment is time consuming and oral 
health is often overlooked. They would be supportive of any measure 
that increased patient and provider awareness of the importance of 
oral health and facilitated referral to a dental home. 
 Dentists – The dentists at the UVM Dental Program are very excited. 
They understand that medical treatment of individuals in recovery is a 
difficult process and are excited to play a more active role in this 
process. They understand that there are barriers for many patients and 
expressed interest in working with individuals to address these concerns. 
They emphasized the importance of a dental home and encouraged 
referral even for patients without acute dental problems. 
Evaluation of Effectiveness and 
Limitations
 Effectiveness can be measured by the number of referrals received 
by the UVM Dental Clinic for patients on Suboxone® for medication 
assisted treatment.  
 Effectiveness can also be measured by provider buy in by recording 
the number of pamphlets are distributed to patients. 
 The greatest limitation is access to dental care. While not all, many 
patients on Suboxone® are on Medicaid which provides limited 
funds for dental care in adults. Furthermore, many dentists don’t 
accept Medicaid patients or accept very few. Offices that do 
accept Medicaid patients often struggle to accommodate these 
patients in a timely fashion. 
Recommendations for Future 
Projects
 Creation of a universal smart phrase or template in PRISM for 
Suboxone® follow-up visits to include a section about oral health in 
an effort to remind providers to make dental referrals and check in 
with patients about oral health.
 The addition of a “dental screening” reminder as part of the Health 
Maintenance section in PRISM for every patient who is receiving 
Suboxone® for treatment.
 An educational session for local Medication Assisted Treatment 
(MAT) teams about the importance of oral health for this population 
and provide resources for dental referrals.
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